Karen Flynn - Net Worth and Insider Trading
Karen Flynn Net Worth
The estimated net worth of Karen Flynn is at least $9 Million dollars as of 2024-11-08. Karen Flynn is the Sr VP & Chief Commercial Offic of West Pharmaceutical Services Inc and owns about 21,593 shares of West Pharmaceutical Services Inc (WST) stock worth over $7 Million. Karen Flynn is the Chief Commercial Officer of Catalent Inc and owns about 33,223 shares of Catalent Inc (CTLT) stock worth over $2 Million. Karen Flynn is also the Director of Societal CDMO Inc and owns about 800 shares of Societal CDMO Inc (SCTL) stock worth over $880. Details can be seen in Karen Flynn's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Karen Flynn has not made any transactions after 2022-01-10 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Karen Flynn
Karen Flynn Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Karen Flynn owns 4 companies in total, including Catalent Inc (CTLT) , Societal CDMO Inc (SCTL) , and West Pharmaceutical Services Inc (WST) among others .
Click here to see the complete history of Karen Flynn’s form 4 insider trades.
Insider Ownership Summary of Karen Flynn
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
CTLT | Catalent Inc | 2022-01-10 | Pres. Biologics & CCO |
SCTL | Societal CDMO Inc | 2016-12-16 | director |
WST | West Pharmaceutical Services Inc | 2018-08-07 | President & America's Region |
2022-06-06 | director |
Karen Flynn Latest Holdings Summary
Karen Flynn currently owns a total of 3 stocks. Among these stocks, Karen Flynn owns 21,593 shares of West Pharmaceutical Services Inc (WST) as of August 7, 2018, with a value of $7 Million and a weighting of 77.81%. Karen Flynn owns 33,223 shares of Catalent Inc (CTLT) as of January 10, 2022, with a value of $2 Million and a weighting of 22.18%. Karen Flynn also owns 800 shares of Societal CDMO Inc (SCTL) as of December 16, 2016, with a value of $880 and a weighting of 0.01%.
Latest Holdings of Karen Flynn
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
WST | West Pharmaceutical Services Inc | 2018-08-07 | 21,593 | 323.42 | 6,983,608 |
CTLT | Catalent Inc | 2022-01-10 | 33,223 | 59.92 | 1,990,722 |
SCTL | Societal CDMO Inc | 2016-12-16 | 800 | 1.10 | 880 |
Holding Weightings of Karen Flynn
Karen Flynn Form 4 Trading Tracker
According to the SEC Form 4 filings, Karen Flynn has made a total of 0 transactions in West Pharmaceutical Services Inc (WST) over the past 5 years. The most-recent trade in West Pharmaceutical Services Inc is the sale of 20,458 shares on August 7, 2018, which brought Karen Flynn around $2 Million.
According to the SEC Form 4 filings, Karen Flynn has made a total of 3 transactions in Catalent Inc (CTLT) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in Catalent Inc is the sale of 2,472 shares on January 10, 2022, which brought Karen Flynn around $288,334.
According to the SEC Form 4 filings, Karen Flynn has made a total of 0 transactions in Societal CDMO Inc (SCTL) over the past 5 years. The most-recent trade in Societal CDMO Inc is the acquisition of 800 shares on December 16, 2016, which cost Karen Flynn around $5,368.
Insider Trading History of Karen Flynn
- 1
Karen Flynn Trading Performance
GuruFocus tracks the stock performance after each of Karen Flynn's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Karen Flynn is 16.48%. GuruFocus also compares Karen Flynn's trading performance to market benchmark return within the same time period. The performance of stocks bought by Karen Flynn within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Karen Flynn's insider trading performs compared to the benchmark.
Karen Flynn Ownership Network
Ownership Network List of Karen Flynn
Ownership Network Relation of Karen Flynn
Karen Flynn Owned Company Details
What does Catalent Inc do?
Who are the key executives at Catalent Inc?
Karen Flynn is the Pres. Biologics & CCO of Catalent Inc. Other key executives at Catalent Inc include SVP & General Counsel & CCO Joseph Anthony Ferraro , Group President & Biologics David Mcerlane , and SVP & Chief HR Officer Lisa Evoli .
Catalent Inc (CTLT) Insider Trades Summary
Over the past 18 months, Karen Flynn made no insider transaction in Catalent Inc (CTLT). Other recent insider transactions involving Catalent Inc (CTLT) include a net sale of 2,740 shares made by Ricky Hopson , a net sale of 1,795 shares made by Scott Gunther , and a net sale of 2,195 shares made by Aristippos Gennadios .
In summary, during the past 3 months, insiders sold 2,314 shares of Catalent Inc (CTLT) in total and bought 0 shares, with a net sale of 2,314 shares. During the past 18 months, 34,661 shares of Catalent Inc (CTLT) were sold and 22,000 shares were bought by its insiders, resulting in a net sale of 12,661 shares.
Catalent Inc (CTLT)'s detailed insider trading history can be found in Insider Trading Tracker table.
Catalent Inc Insider Transactions
Karen Flynn Mailing Address
Above is the net worth, insider trading, and ownership report for Karen Flynn. You might contact Karen Flynn via mailing address: C/o Catalent, Inc., 14 Schoolhouse Road, Somerset Nj 08873.